Bellevue Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-24,600
| Closed | -$935K | – | 183 |
|
|
2023
Q4 | $935K | Sell |
24,600
-24,200
| -50% | -$920K | 0.01% | 124 |
|
|
2023
Q3 | $895K | Hold |
48,800
| – | – | 0.01% | 130 |
|
|
2023
Q2 | $1.27M | Buy |
48,800
+19,100
| +64% | +$496K | 0.02% | 122 |
|
|
2023
Q1 | $560K | Hold |
29,700
| – | – | 0.01% | 140 |
|
|
2022
Q4 | $732K | Sell |
29,700
-13,800
| -32% | -$340K | 0.01% | 144 |
|
|
2022
Q3 | $781K | Sell |
43,500
-33,100
| -43% | -$594K | 0.01% | 141 |
|
|
2022
Q2 | $869K | Buy |
76,600
+26,900
| +54% | +$305K | 0.01% | 139 |
|
|
2022
Q1 | $1.11M | Sell |
49,700
-800
| -2% | -$17.8K | 0.01% | 147 |
|
|
2021
Q4 | $2.21M | Buy |
+50,500
| New | +$2.21M | 0.02% | 144 |
|